Arkolith/Insider Trading/GYRE/Form 4

Ye Weiguo

Chief Operating OfficerGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed Apr 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2025Option exercise(M)150K$0.75$113K650K
Mar 26, 2025Option exercise(M)200K$0.75$150K500K
Mar 24, 2025Option exercise(M)300K$0.75$225K300K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 27, 2025Option exercise(M)150K—$01.0M
Mar 26, 2025Option exercise(M)200K—$01.2M
Mar 24, 2025Option exercise(M)300K—$01.4M

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-015712) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML